Fig. 1From: Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort studyKaplan-Meier curves of biomarkers from the time of inclusion to disease relapse. a Calprotectin serum levels. b Power Doppler score. c Tumor necrosis factor inhibitors (TNFi) trough serum levelsBack to article page